vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Enpro Inc. (NPO). Click either name above to swap in a different company.
Enpro Inc. is the larger business by last-quarter revenue ($295.4M vs $284.0M, roughly 1.0× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -10.8%, a 107.2% gap on every dollar of revenue. On growth, Enpro Inc. posted the faster year-over-year revenue change (14.3% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 7.1%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Enpro is a US-based industrial technology company that designs and manufactures products and materials for technology-intensive sectors. The company serves industries such as semiconductors, aerospace, power generation, heavy-duty trucking, agricultural machinery, chemical processing, pulp and paper, and life sciences from 61 primary manufacturing facilities located in 12 countries, worldwide. It is organized under three segments: Sealing Technologies, Advanced Surface Technologies, and Engin...
ACAD vs NPO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $295.4M |
| Net Profit | $273.6M | $-32.0M |
| Gross Margin | 90.8% | 42.1% |
| Operating Margin | 6.1% | 11.2% |
| Net Margin | 96.3% | -10.8% |
| Revenue YoY | 9.4% | 14.3% |
| Net Profit YoY | 90.3% | -330.2% |
| EPS (diluted) | $1.61 | $-1.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $295.4M | ||
| Q3 25 | $278.6M | $286.6M | ||
| Q2 25 | $264.6M | $288.1M | ||
| Q1 25 | $244.3M | $273.2M | ||
| Q4 24 | $259.6M | $258.4M | ||
| Q3 24 | $250.4M | $260.9M | ||
| Q2 24 | $242.0M | $271.9M | ||
| Q1 24 | $205.8M | $257.5M |
| Q4 25 | $273.6M | $-32.0M | ||
| Q3 25 | $71.8M | $21.6M | ||
| Q2 25 | $26.7M | $26.4M | ||
| Q1 25 | $19.0M | $24.5M | ||
| Q4 24 | $143.7M | $13.9M | ||
| Q3 24 | $32.8M | $19.8M | ||
| Q2 24 | $33.4M | $26.7M | ||
| Q1 24 | $16.6M | $12.5M |
| Q4 25 | 90.8% | 42.1% | ||
| Q3 25 | 92.2% | 41.9% | ||
| Q2 25 | 92.2% | 43.3% | ||
| Q1 25 | 91.7% | 43.3% | ||
| Q4 24 | 91.6% | 42.3% | ||
| Q3 24 | 92.5% | 42.3% | ||
| Q2 24 | 92.5% | 43.8% | ||
| Q1 24 | 88.8% | 41.2% |
| Q4 25 | 6.1% | 11.2% | ||
| Q3 25 | 12.8% | 14.3% | ||
| Q2 25 | 12.2% | 15.9% | ||
| Q1 25 | 7.9% | 15.3% | ||
| Q4 24 | 59.1% | 12.5% | ||
| Q3 24 | 12.6% | 13.1% | ||
| Q2 24 | 12.6% | 17.7% | ||
| Q1 24 | 7.4% | 10.9% |
| Q4 25 | 96.3% | -10.8% | ||
| Q3 25 | 25.8% | 7.5% | ||
| Q2 25 | 10.1% | 9.2% | ||
| Q1 25 | 7.8% | 9.0% | ||
| Q4 24 | 55.4% | 5.4% | ||
| Q3 24 | 13.1% | 7.6% | ||
| Q2 24 | 13.8% | 9.8% | ||
| Q1 24 | 8.0% | 4.9% |
| Q4 25 | $1.61 | $-1.50 | ||
| Q3 25 | $0.42 | $1.01 | ||
| Q2 25 | $0.16 | $1.25 | ||
| Q1 25 | $0.11 | $1.15 | ||
| Q4 24 | $0.86 | $0.65 | ||
| Q3 24 | $0.20 | $0.94 | ||
| Q2 24 | $0.20 | $1.27 | ||
| Q1 24 | $0.10 | $0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $114.7M |
| Total DebtLower is stronger | — | $655.3M |
| Stockholders' EquityBook value | $1.2B | $1.5B |
| Total Assets | $1.6B | $2.7B |
| Debt / EquityLower = less leverage | — | 0.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $114.7M | ||
| Q3 25 | $258.0M | $132.9M | ||
| Q2 25 | $253.6M | $107.1M | ||
| Q1 25 | $217.7M | $240.3M | ||
| Q4 24 | $319.6M | $236.3M | ||
| Q3 24 | $155.1M | $206.9M | ||
| Q2 24 | $177.1M | $175.9M | ||
| Q1 24 | $204.7M | $163.9M |
| Q4 25 | — | $655.3M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $640.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $644.9M |
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | $917.3M | $1.5B | ||
| Q2 25 | $822.4M | $1.5B | ||
| Q1 25 | $765.2M | $1.5B | ||
| Q4 24 | $732.8M | $1.4B | ||
| Q3 24 | $577.2M | $1.5B | ||
| Q2 24 | $516.7M | $1.4B | ||
| Q1 24 | $464.0M | $1.4B |
| Q4 25 | $1.6B | $2.7B | ||
| Q3 25 | $1.3B | $2.4B | ||
| Q2 25 | $1.2B | $2.4B | ||
| Q1 25 | $1.1B | $2.5B | ||
| Q4 24 | $1.2B | $2.5B | ||
| Q3 24 | $976.9M | $2.5B | ||
| Q2 24 | $914.1M | $2.5B | ||
| Q1 24 | $855.1M | $2.5B |
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.45× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.46× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 4.1% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | — | ||
| Q3 25 | $74.3M | $65.3M | ||
| Q2 25 | $64.0M | $52.2M | ||
| Q1 25 | $20.3M | $21.0M | ||
| Q4 24 | $40.4M | $59.4M | ||
| Q3 24 | $63.2M | $54.0M | ||
| Q2 24 | $25.0M | $43.2M | ||
| Q1 24 | $29.1M | $6.3M |
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | $53.4M | ||
| Q2 25 | — | $42.3M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $49.1M | ||
| Q3 24 | $63.2M | $48.3M | ||
| Q2 24 | — | $38.3M | ||
| Q1 24 | — | $-1.9M |
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | 18.6% | ||
| Q2 25 | — | 14.7% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 19.0% | ||
| Q3 24 | 25.2% | 18.5% | ||
| Q2 24 | — | 14.1% | ||
| Q1 24 | — | -0.7% |
| Q4 25 | — | 4.1% | ||
| Q3 25 | 0.1% | 4.2% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | 0.0% | 2.2% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | 3.02× | ||
| Q2 25 | 2.40× | 1.98× | ||
| Q1 25 | 1.07× | 0.86× | ||
| Q4 24 | 0.28× | 4.27× | ||
| Q3 24 | 1.93× | 2.73× | ||
| Q2 24 | 0.75× | 1.62× | ||
| Q1 24 | 1.76× | 0.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
NPO
| Sealing Technologies Segment | $187.0M | 63% |
| General Industrial | $71.3M | 24% |
| Power Generation | $19.9M | 7% |
| Oiland Gas Market | $15.0M | 5% |
| Semiconductors | $2.2M | 1% |
